Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · May 16, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new mobile app called CarePair, which is designed to help family caregivers who look after loved ones with dementia. The goal of the study is to see if using this app can help reduce the stress and emotional strain that caregivers often experience, making them feel better overall. Researchers want to find out if using CarePair can make caregivers feel less depressed and more confident in their ability to care for their family members.
To participate in the trial, caregivers must be at least 18 years old and provide care for a person with dementia for at least 10 hours a week. They should also be comfortable using the internet and speak English. Participants will use the CarePair app for six weeks and complete some activities during that time. The researchers will compare the experiences of those using the app to those in a control group who will not use it, to see if the app truly helps improve caregivers' well-being. This study is not yet recruiting participants, but it could be a significant opportunity for caregivers to find support and resources.
Gender
ALL
Eligibility criteria
- Inclusion:
- • Currently a primary caregiver of a community-dwelling PwD
- • Provides at least 10 hours of care per week
- • ≥18 years of age
- • Fluent in English
- • Both the caregiver and care-recipient reside in and/or can easily access one of the following cities/areas: New York City, New York (NY); Long Island, NY; Westchester County, NY; Seattle, Washington (WA); Los Angeles, California (CA)
- • Provides at least 10 hours of care per week
- • Has provided care for at least 6 months
- • Able to use the internet and has internet access
- • Owns and can operate a smartphone
- • Able and willing to provide their informed consent to participate for the six-week study duration
- • Does not self-report any cognitive impairments
- Exclusion:
- • Not currently the primary caregiver of a community-dwelling person with dementia
- • Care-recipient lives in residential care (e.g., assisted living, skilled nursing facility)
- • ≤18 years of age
- • Not fluent in English
- • The caregiver and/or care-recipient resides outside of and/or cannot easily access any of the following cities: New York City (NY); Long Island (NY); Westchester County (NY); Seattle (WA); Los Angeles (CA)
- • Provides less than 10 hours of care per week
- • Has provided care for less than 6 months
- • Unable to use the internet or does not have internet access
- • Does not own and/or cannot operate a smartphone
- • Unable or unwilling to provide informed consent to participate for the six-week study duration
- • Self-reports having a cognitive impairment
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Francesca Falzarano, PhD
Principal Investigator
University of Southern California
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported